Effect of tyrphostin AG879 on Kv4.2 and Kv4.3 potassium channels

作者: Haibo Yu , Beiyan Zou , Xiaoliang Wang , Min Li

DOI: 10.1111/BPH.13127

关键词: BK channelChemistryTransfectionPotassium channelShal Potassium ChannelsMolecular biologySK channelT-type calcium channelPotassium channel blockerInward-rectifier potassium ion channelBiophysics

摘要: Background and Purpose A-type potassium channels (IA) are important proteins for modulating neuronal membrane excitability. The expression activity of Kv4.2 critical neurological functions pharmacological inhibitors may have therapeutic potential Fragile X syndrome. While screening various compounds, we identified tyrphostin AG879, a tyrosine kinase inhibitor, as inhibitor from. In the present study characterized effect AG879 on cloned Kv4.2/Kv channel-interacting protein 2 (KChIP2) channels. Experimental Approach To screen library pharmacologically active thallium flux assay was performed HEK-293 cells transiently-transfected with cDNA using Maxcyte transfection system. effects were further examined CHO-K1 expressing Kv4.2/KChIP2 whole-cell patch-clamp technique. Key Results Tyrphostin selectively dose-dependently inhibited Kv4.3 channels. channels, induced prominent acceleration inactivation rate, use-dependent block slowed recovery from inactivation. hyperpolarizing shift in voltage-dependence steady-state without apparent V1/2 voltage-dependent activation. blocking enhanced channel increased. Furthermore, significantly A-type currents cultured hippocampus neurons. Conclusion Implications AG879 selective potent channel. by preferentially interacting open state accelerating their

参考文章(45)
A Levitzki, E Manser, H Maruta, H He, L Lim, Y Hirokawa, Signal therapy for RAS-induced cancers in combination of AG 879 and PP1, specific inhibitors for ErbB2 and Src family kinases, that block PAK activation. Cancer Journal. ,vol. 7, pp. 191- 202 ,(2001)
Shi-Ying Li, Bin-Bin Huang, Shou Ouyang, Effect of genistein on voltage-gated potassium channels in guinea pig proximal colon smooth muscle cells World Journal of Gastroenterology. ,vol. 12, pp. 420- 425 ,(2006) , 10.3748/WJG.V12.I3.420
Dax A. Hoffman, Jeffrey C. Magee, Costa M. Colbert, Daniel Johnston, K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons Nature. ,vol. 387, pp. 869- 875 ,(1997) , 10.1038/43119
Carol Kilkenny, William Browne, Innes C Cuthill, Michael Emerson, Douglas G Altman, None, Animal research: reporting in vivo experiments: the ARRIVE guidelines British Journal of Pharmacology. ,vol. 160, pp. 1577- 1579 ,(2010) , 10.1111/J.1476-5381.2010.00872.X
Stephen L. Hoffman, William H. Bancroft, Gottlieb Michael, Stephanie L. James, Enriqueta C. Bond Burroughs, John R. Stephenson, Michael J. Morgan, Funding for malaria genome sequencing Nature. ,vol. 387, pp. 647- 647 ,(1997) , 10.1038/42571
Stephen P.H. Alexander, Helen E. Benson, Elena Faccenda, Adam J. Pawson, Joanna L. Sharman, William A. Catterall, Michael Spedding, John A. Peters, Anthony J. Harmar, , The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels British Journal of Pharmacology. ,vol. 170, pp. 1607- 1651 ,(2013) , 10.1111/BPH.12447
S. Nattel, B. Fermini, Zhiguo Wang, Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. Journal of Pharmacology and Experimental Therapeutics. ,vol. 272, pp. 184- 196 ,(1995)
Stephen P.H. Alexander, Helen E. Benson, Elena Faccenda, Adam J. Pawson, Joanna L. Sharman, Michael Spedding, John A. Peters, Anthony J. Harmar, , The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors British Journal of Pharmacology. ,vol. 170, pp. 1676- 1705 ,(2013) , 10.1111/BPH.12449
M T Slawsky, N A Castle, K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. Journal of Pharmacology and Experimental Therapeutics. ,vol. 269, pp. 66- 74 ,(1994)
K M Knoth, S L Roberds, M M Tamkun, J Snyders, Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Molecular Pharmacology. ,vol. 41, pp. 322- 330 ,(1992)